Dual inhibition of PI3K and mTOR in cancer therapy: Mechanisms, clinical potential, and future perspectives.
The PI3K/AKT/mTOR signaling system is essential for controlling cell growth, survival, proliferation, and metabolism, rendering it a significant therapeutic target in cancer treatment. Dysregulation of this system is commonly reported in numerous cancers, facilitating tumor development and resistanc...
| Publicado en: | Pharmacy Practice (1886-3655) Vol. 24; no. 1; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas S.L.
Jan-Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |